Genmab makes two C-suite additions as COO leaves; James Sabry leads a revamped supporting cast at BioMarin

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Doc Manipulated Organ Database? Hospital Board Targeted; Biotech Security Threat?

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Texas Surgeon Accused of Making Transplant

April 18, 2024

European Commission approves Illumina’s proposed Grail split

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: The European Commission has approved

April 15, 2024

Animal rights group urges SEC to investigate Charles River over monkey purchases

A leading animal rights group has asked securities regulators to investigate Charles River Laboratories for allegedly misleading investors about its sales and purchases of long-tailed

April 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.